Betahistine Dihydrochloride IP 8 Mg

This lower 8 mg strength is a synthetic histamine analog specifically utilized as an introductory or maintenance therapy for patients suffering from Ménière's disease, an inner ear condition characterized by debilitating vertigo (spinning dizziness), tinnitus (constant ringing in the ears), nausea, and progressive hearing loss. The active drug functions by dilating the tiny blood vessels to improve microcirculation within the inner ear chambers, which directly facilitates the drainage of trapped, excess endolymphatic fluid and relieves the internal pressure causing balance disruption. About the Company Legal Status of Firm: Limited Company Number of Employees: Upto 10 People Annual Turnover: 0 - 40 L